Home Page ::: Clinical Anti-Inflammatory & Anti-Allergy Drugs

ISSN: 2212-7046 (Online)
ISSN: 2212-7038 (Print)


Volume 1, 2 Issues, 2014






Clinical Anti-Inflammatory & Anti-Allergy Drugs

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Giovanni Passalacqua


Allergy & Respiratory Diseases
Department of Internal Medicine
University of Genova
Genova
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints



Clinical Anti-Inflammatory & Anti-Allergy Drugs

,

Volume 1

-

Number 1



Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

; Pp: 2 - 10

Lawren C. Wu, Joseph R. Arron, Jeffrey M. Harris, John G. Matthews and Karin Rosen


DOI: 10.2174/2212703801999131206110837
View Abstract Download Free Rights and Permissions

  
  



Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody

; Pp: 24 - 31

Hans D. Brightbill, Yuwen L. Lin, Zhonghua Lin, Martha Tan, Y. Gloria Meng, Mercedesz Balazs, Shan Chung and Lawren C. Wu


DOI: 10.2174/22127038114019990003
View Abstract Download Free Rights and Permissions

  
  



Activin-A: A New Piece in the Puzzle of Tolerance in Asthma

; Pp: 45 - 56

Sofia Tousa, Maria Semitekolou, Ioannis Morianos, Aikaterini I Trochoutsou and Georgina Xanthou


DOI: 10.2174/2212703801666140221004020
View Abstract Download Free Rights and Permissions

  
  



Hydrogen Sulfide: A New Tool to Design and Develop Drugs

; Pp: 57 - 66

Nethaji Muniraj, Abel Damien Ang, Alireza Badiei, Jack Rivers-Auty and Madhav Bhatia


DOI: 10.2174/2212703801666140311005131
View Abstract Download Free Rights and Permissions

  
  



Advertisement

Related Journals




Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science